REVELATION BIOSCIENCES, INC. Deferred Revenue (Non-Current)
REVELATION BIOSCIENCES, INC. (REVB) had Deferred Revenue (Non-Current) of $2.91 million as of 2021-12-31, per its 10-K filed 2022-04-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueNoncurrent · last filed 2022-04-15
- 2021-12-31: Deferred Revenue, Noncurrent $2.91M.
- 2021-09-30: Deferred Revenue, Noncurrent $2.91M.
- 2021-06-30: Deferred Revenue, Noncurrent $2.91M.
- 2021-03-31: Deferred Revenue, Noncurrent $2.91M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2021-12-31 | $2.91M 10-K · filed 2022-04-15 |
| 2021-09-30 | $2.91M 10-Q · filed 2021-10-29 |
| 2021-06-30 | $2.91M 10-Q · filed 2021-08-23 |
| 2021-03-31 | $2.91M 10-Q · filed 2021-06-22 |
| 2020-12-31 | $2.91M 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |